Harbin Pharmaceutical Group Co Ltd. Stock Analysis 600664.SS

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, wholesale and retail of pharmaceutical products. The company is headquartered in Harbin, Heilongjiang and currently employs 10,039 full-time employees. The firm is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The firm's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The firm's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.